We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say

News   Jun 30, 2009

 
FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say
 
 
Advertisement
 

RELATED ARTICLES

Trial of Saliva Test for COVID-19 Launched

News

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.

READ MORE

Existing Drugs Could Stop SARS-CoV-2 From Hijacking Cells

News

A team has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells. The scientists have also identified seven existing drugs that could disrupt these mechanisms.

READ MORE

Rewriting the Rules of Vaccine Design With DNA Origami

News

By folding DNA into a virus-like structure, MIT researchers have designed HIV-like particles that provoke a strong immune response from human immune cells grown in a lab dish. Such particles might eventually be used as an HIV vaccine.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE